Tech Company Financing Transactions
Life Molecular Imaging Funding Round
Life Molecular Imaging secured a investment round on 5/20/2025. Investors included Alzheimer's Drug Discovery Foundation.
Transaction Overview
Company Name
Announced On
5/20/2025
Transaction Type
Amount
Unknown
Round
Undisclosed
Investors
Alzheimer's Drug Discovery Foundation (Howard Fillit)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Manufacturing
Mailing Address
Tegeler Str. 6-7
Berlin, 13353
Germany
Berlin, 13353
Germany
Phone
Undisclosed
Website
Email Address
Overview
With the development of novel PET tracers for molecular imaging, Life Molecular Imaging (LMI) is focusing on a key area of modern medicine. LMI strives to be a leader in the field of molecular imaging by developing innovative products that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Michel Jongens
Chief Financial Officer
Adrian Karasiewicz
Chief Medical Officer
Andrew Stephens
Chief Operating Officer
Colleen Ruby
Chief Technical Officer
Mathias Berndt
Founder
Ludger Dinkelborg
VP - Bus. Development
Nico Beukman
VP - Human Resources
Daniela Menzel
Browse more venture capital transactions:
Prev: 5/20/2025: SparkCharge venture capital transaction
Next: 5/20/2025: Butternut Box venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs